 |
|
Dose of remifentanil for minimizing the cardiovascular changes to tracheal intubation in pediatric patients
Sang-Ho Yoon, Kyung-Han Kim, Suk-Hwan Seo
Korean J Anesthesiol. 2010;59(3):167-172. Published online 2010 Sep 20 DOI: https://doi.org/10.4097/kjae.2010.59.3.167
|
|
Citations to this article as recorded by
 Optimal neuromuscular blocking effects of remifentanil during tracheal intubation under general anesthesia
So Young Kwon, Si Wook Chung, Jin Deok Joo
Journal of International Medical Research.2018; 46(8): 3097. CrossRef Pharmacological Agents for Reducing the Haemodynamic Response to Tracheal Intubation in Paediatric Patients: A Systematic Review
M. Nazir, B. Salim, F. A. Khan
Anaesthesia and Intensive Care.2016; 44(6): 681. CrossRef Pediatric Ambulatory Anesthesia
David A. August, Lucinda L. Everett
Anesthesiology Clinics.2014; 32(2): 411. CrossRef Management of the airway without the use of neuromuscular blocking agents: the use of remifentanil
Georgia Fotopoulou, Stamatios Theocharis, Ioanna Vasileiou, Evangelia Kouskouni, Theodoros Xanthos
Fundamental & Clinical Pharmacology.2012; 26(1): 72. CrossRef The median effective effect-site concentration of remifentanil for minimizing the cardiovascular changes to endotracheal intubation during desflurane anesthesia in pediatric patients
Eun-Jung Kim, Sang-Wook Shin, Tae-Kyun Kim, Ji-Uk Yoon, Gyeong-Jo Byeon, Hye-Jin Kim
Korean Journal of Anesthesiology.2012; 63(4): 314. CrossRef
|